InfraScan to Present at “Investment In Innovation (In3) WEST” Conference
Read more here


NuPathe Licenses Novel Drug Delivery Technology from University of Pennsylvania
Read more here


InfraScan Announces First Patients Enroll in Clinical Trial in Brain Hematoma Detection
Read more here


BioAdvance Invests In Midway Pharmaceuticals to Support Promising Development Program for GI Therapies
Read more here


InfraScan to Present at Medtech Insight and Windhover Information’s “Investment In Innovation (In3) WEST” Conference
Read more here